You are here

Merck

Novartis Declines As Merck Wins Patent Battle

Bidness, ETC

Fri, 08/21/15 - 09:47 am

Former U.S. President Carter gets powerful immune-system boosting drug

Yahoo/Reuters

Fri, 08/21/15 - 08:47 am

anti-PD-1 immunotherapy

The 2013 Merck-Pfizer Diabetes Deal Now Looks Very Savvy

Forbes

Thu, 08/20/15 - 03:14 pm

Big Pharma still a big deal for NJ economy, despite cost cuts

Fierce Pharma

Wed, 08/19/15 - 12:21 pm

Bristol-Myers Squibb

Merck job-cutting tensions displayed in public emails from Frazier, union rep

Fierce Pharma

Wed, 08/19/15 - 12:20 pm

Kenneth Frazier

Intarcia’s diabetes treatment beats $6B Merck drug in head-to-head trial

Bizjournals.com

Tue, 08/18/15 - 09:26 pm

type 2 diabetes

Merck recalls 276,000 bottles of chemotherapy pill because child-proof cap may be cracked

Yahoo/AP

Tue, 08/18/15 - 04:15 pm

Merck's Keytruda ready for quick FDA action on big melanoma expansion

Fierce Pharma

Tue, 08/18/15 - 01:36 pm

4 Top Pharma Stocks That Should Outperform Out To 2016

24/7 Wall St

Tue, 08/18/15 - 09:44 am

Bristol-Myers Squibb

Did Merck and NewLink Genetics Just Cure Ebola?

Motley Fool

Sun, 08/16/15 - 10:28 am

NewLink Genetics

Immuno-oncology deal frenzy continues as Merck partners with M.D. Anderson

Fierce Biotech

Thu, 08/13/15 - 10:24 am

immuno-oncology

Immune Design and Merck to Collaborate on Combination Trials of Two Immune Design Immunotherapies With Merck's KEYTRUDA for Non-Hodgkin's Lymphoma and Melanoma

Yahoo

Mon, 08/10/15 - 08:08 am

clinical trials

non-Hodgkin's lymphoma

Merck Targets Toughest Cases to Gain Hepatitis C Foothold

Bloomberg

Mon, 08/3/15 - 05:10 pm

Gilead Sciences

grazoprevir/elbasvir

Merck should follow GSK’s lead and commit to selling its potential Ebola vaccine at cost

Bizjournals.com

Sun, 08/2/15 - 11:21 am

Will Merck's 100% effective Ebola vaccine make money?

CNBC

Sat, 08/1/15 - 08:58 am

5 Key Points You May Have Missed in Merck's Q2 Report

Motley Fool

Fri, 07/31/15 - 03:30 pm

Finally: Merck Ebola vax triumphs in phase III trial, overcoming logistical nightmare

BioPharma Dive

Fri, 07/31/15 - 11:14 am

clinical trials

Eyeing big returns, drugmakers ready new hepatitis-C drug launches

Medical Marketing and Media

Wed, 07/29/15 - 09:46 pm

grazoprevir/elbasvir

Gilead Sciences

Merck's Keytruda gains market share in Q2

Medical Marketing and Media

Wed, 07/29/15 - 10:33 am

anti-PD-1 immunotherapy

Bristol-Myers Squibb

Merck signs a $605M deal to bulk up in cancer immunotherapy

Fierce Biotech

Wed, 07/29/15 - 10:17 am

cancer immunotherapy

cCAM Biotherapeutics

Pages